Designing bioequivalence studies--how much of a difference is acceptable?
Ricardo
R
Savaris
D000964:Antimetabolites, Antineoplastic / Q000493:pharmacokinetics; D005260:Female; D006801:Humans; D008727:Methotrexate / Q000493:pharmacokinetics*; D011247:Pregnancy; D011271:Pregnancy, Ectopic / Q000188:drug therapy / Q000453:epidemiology*; D011446:Prospective Studies; D015203:Reproducibility of Results; D013810:Therapeutic Equivalency; D016896:Treatment Outcome
D000964:Antimetabolites, Antineoplastic; D008727:Methotrexate